Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation

Details for Australian Patent Application No. 2004264316 (hide)

Owner Alza Corporation

Inventors Shivanand, Padmaja; Reyes, Iran; Wong, Patrick S.L.; Yam, Noymi V.; Li, Shaoling

Agent Shelston IP

Pub. Number AU-A-2004264316

PCT Pub. Number WO2005/016306

Priority 60/493,371 06.08.03 US

Filing date 3 August 2004

Wipo publication date 24 February 2005

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016306 Priority application(s): WO2005/016306

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264319-Method and device for enhancing transdermal agent flux

2004264314-New diabetes type 2 animal model